Scientists dig into DNA to unravel blood clot mysteries in rare disorder
NCT ID NCT05233384
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at people with a rare inherited condition called dysfibrinogenemia, which affects how blood clots form. Researchers collected blood samples from 70 patients to analyze clot structure and search for genetic variations that might explain why some patients bleed while others develop dangerous clots. The goal is to better understand each person's unique clotting profile and eventually guide more personalized treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors better predict whether a patient with dysfibrinogenemia is more likely to bleed or clot, leading to more personalized care.
- What could go wrong
- This is an observational study with only 70 participants, so findings may not apply to everyone. It is early-stage research, not a treatment trial, so direct patient benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY DYSFIBRINOGENEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Dijon
Dijon, France
-
CHU Montpellier
Montpellier, France
-
CHU Nantes
Nantes, France
-
CHU Tours
Tours, France
-
CHU clermont-ferrand
Clermont-Ferrand, France
-
CHU de Lille
Lille, France
-
CHu Nancy
Nancy, France